Mytinib 400 mg Tablet
5.21$
4.42$
Mytinib 400 mg Tablet is a targeted anticancer therapy designed to combat specific types of leukemia, which is a malignancy affecting the white blood cells, as well as various blood-related cancers. This medication is particularly effective against gastrointestinal stromal tumors (GIST), which originate in the digestive tract's walls and may metastasize to other areas. Additionally, Mytinib is indicated for treating protuberant tumors that are inoperable, have spread beyond their initial site, or have returned post-surgery. By inhibiting specific molecular pathways that promote tumor growth, Mytinib helps to slow down or halt the progression of these cancers. It is crucial for patients to discuss potential side effects and contraindications with their healthcare provider, as certain conditions may exacerbate the treatment's risks. Regular monitoring during therapy is essential to ensure efficacy and safety. Overall, Mytinib 400 mg serves as a vital option in the fight against challenging malignancies, providing hope for improved outcomes in affected individuals.
الكمية
Active Pharmaceutical Ingredient
Uses
• Mytinib 400 mg tablet is primarily indicated for the treatment of Chronic Myelogenous Leukemia (CML). This condition involves the overproduction of abnormal white blood cells in the bone marrow. By targeting specific pathways involved in cell growth, Mytinib 400 mg tablet helps to manage the proliferation of these cells. As a result, patients may experience improved blood cell counts and overall health.
• In patients diagnosed with CML, Mytinib 400 mg tablet is utilized to inhibit the activity of the BCR-ABL protein, which plays a crucial role in the disease's progression. This mechanism helps to slow down or halt the advancement of the cancer. By effectively controlling the disease, Mytinib 400 mg tablet can enhance the quality of life for those affected. Regular use can lead to better treatment outcomes over time.
• Mytinib 400 mg tablet is often prescribed as a part of a long-term management plan for individuals with chronic myelogenous leukemia. It is typically used after the diagnosis has been confirmed and may be combined with other supportive therapies. Patients taking Mytinib 400 mg tablet may find that it helps them maintain a more stable condition. This stability is essential for managing symptoms and preventing complications associated with CML.
• For individuals with CML, Mytinib 400 mg tablet serves as a cornerstone of targeted therapy. Its ability to specifically block the signals that drive cancer cell growth makes it a valuable option. This targeted approach can lead to a reduction in disease symptoms and improve treatment efficacy. As a result, many patients rely on Mytinib 400 mg tablet to help manage their chronic condition effectively.
Benefits
Mytinib 400 mg Tablet helps to reduce the size of cancerous tumors and slow the growth of cancer cells.
Mytinib Tablet can be used as part of a treatment plan to help increase the chances of remission or cure in patients with certain types of cancer.
Mytinib 400 mg Tablet can help to reduce the number and severity of cancer-related symptoms, such as fatigue, pain, and nausea.
Mytinib 400 mg Tablet can be taken orally, which makes it easier for patients to take the medication, and Mytinib 400 mg Tablet has relatively few side effects compared to other cancer treatments, such as chemotherapy.
Side Effects
Adverse reactions may occur with the use of Mytinib 400 mg Tablet. Should you notice any of these side effects, it is advisable to consult your doctor or healthcare professional without delay. Your doctor can offer guidance on managing or alleviating these side effects.
Most Common Side Effects
• Nausea
• Vomiting
• Joint Pain
• Bone pain
• Muscle Cramps
• Sweating
• Watery Eyes
• Pink Eyes
• Flushing
• Itching
• Hair loss
Common Side Effects
• Shortness Of Breath
• Irregular Heartbeats
• Chest Pain
• Blistered skin
• Blood in Stool
• Severe Abdominal Pain and Bloating
• Blood in sputum
• High Fever
• Intestinal Bleeding
• Hepatic problems
• Diarrhea
• Dry mouth
• Loss of appetite
• Weight loss
• Headache
• Nail Color Changes
• Chills
• Sore throat
• Frequent Urination
• Tiredness
How To Use
Mytinib 400 mg can be taken with food or as directed by your doctor. It is best to take the same time daily to improve the clinical condition. If you miss a dose of Mytinib 400 mg Tablet take your next dose at your regularly scheduled time. The dose and duration of remedy will depend upon your condition. Do not stop taking this medicine without consulting your doctor.
Safety Advice
• Alcohol: The consumption of alcohol is generally not recommended when using Mytinib Tablet due to the increased risk of liver damage. It is best to either avoid alcohol altogether or limit its consumption while undergoing any medication.
• Kidney: Mytinib 400 mg Tablet should be used with mild kidney disease patients (CrCl 40 to <60 mL/min): Doses >600 mg/day are not recommended and moderate kidney patients (CrCl 20 to <40 mL/min). Decrease dose by 50%; may increase future doses if tolerated. Mytinib 400 mg Tablet used in caution patients with severe kidney disease take 100-mg/day dose was tolerated.
• Breastfeeding: The excretion of Mytinib Tablet in human milk is currently unknown. Considering that various drugs, including other anthracyclines, are excreted in human milk and the possibility of severe adverse reactions in nursing infants from Mytinib 400 mg Tablet, it is recommended that lactating women refrain from breastfeeding while undergoing treatment with Mytinib Tablet and for a minimum of 7 days after the final dose.
• Liver: Patients with liver disease should exercise caution when using Mytinib 400 mg Tablet. It is crucial for individuals with liver disease to closely observe their liver function while using Mytinib 400 mg Tablet and promptly inform their physician of any abnormal symptoms or changes in liver function. Adjustments to the dosage of Mytinib 400 mg Tablet may be necessary for patients with liver disease.
• Pregnancy: The use of Mytinib 400 mg Tablet during pregnancy may not be safe, as indicated by animal studies that suggest potential harm to the developing foetus. However, if you are currently pregnant or planning to become pregnant, it is crucial to consult your doctor about the potential risks and benefits of using Mytinib 400 mg Tablet during pregnancy. Your doctor will be able to assist you in making the most appropriate decision for the health and well-being of both you and your baby.
• Driving: Your doctor's instructions should be strictly followed, especially if you encounter any side effects from Mytinib 400 mg Tablet. These side effects, such as dizziness, fatigue, and difficulty concentrating and coordinating, have the potential to hinder your capability to drive a vehicle safely. Taking necessary precautions, such as refraining from driving or operating heavy machinery, is essential to ensure your well-being while using Mytinib Tablet.